3-Iodo-1-(trifluoromethyl)bicyclo[1.1.1]pentane, 97%, 1g

4-HYDROXY-1-METHYL-2-PYRIDONE, 95.0%, 250mg

1-(2-MORPHOLINOETHYL)PYRROLIDIN-3-AMINE, 95.0%, 250mg

6-Amino-2-methylpyridin-3-ol, 98%, 1g

2-chloro-N-(3,5-di-tert-butylphenyl)acetamide, 95.0%, 500mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 25 µl, 1702 RNR, 1 piece

1-Ethoxy-4-(trans-4-pentylcyclohexyl)benzene>98.0%(GC)5g

Methacryloxypropyl terminated polydimethylsiloxane, 1000 cSt, 100g

Cyclobutyl(2,3-dihydrobenzofuran-5-yl)methanamine, 98%, 100mg

7,7-Dimethyl-1,4-dioxaspiro[4.5]decan-8-ol, 98%, 100mg

4-(1H-imdazol-4-yl)piperidine, 95.0%, 5g

5-Amino-4-chloropyridazin-3(2H)-one, 95.0%, 5g

Ethyl 3-(2-chlorophenyl)propanoate, 95.0%, 1g